Doo-Hun Kim
Förmögenhet: 107 662 $ per 2026-06-30
Förmögenhet: 107 662 $ per 2026-06-30
Doo-Hun Kim currently works at Feyman Asset Management Co., Ltd., as Chief Executive Officer and AbClon, Inc., as Chief Financial Officer & Executive Director from 2024.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ABCLON, INC. 0,03 % | 2026-04-27 | 6 000 ( 0,03 % ) | 107 662 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ABCLON INC. | Finansdirektör/CFO | 2024-03-28 |
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 2 |
|---|---|
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Finance |
AbClon, Inc.
AbClon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of antibody drugs | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån